Cargando…

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda

Detalles Bibliográficos
Autores principales:	Lubinga, Solomon J., Atukunda, Esther C., Wasswa-Ssalongo, George, Babigumira, Joseph B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816505/ https://www.ncbi.nlm.nih.gov/pubmed/27031709 http://dx.doi.org/10.1371/journal.pone.0152955

Ejemplares similares

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial
por: Atukunda, Esther C., et al.
Publicado: (2014)

Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
por: Rajaei, Minoo, et al.
Publicado: (2014)

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach
por: Koch, Daeska Marcella, et al.
Publicado: (2019)

Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia
por: Smith, Jeffrey Michael, et al.
Publicado: (2014)

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
por: Prata, Ndola, et al.
Publicado: (2014)

Study protocol: using a mobile phone-based application to increase awareness and uptake of sexual and reproductive health services among the youth in Uganda. A randomized controlled trial
por: Nuwamanya, Elly, et al.
Publicado: (2018)

Study protocol: incentives for increased access to comprehensive family planning for urban youth using a benefits card in Uganda. A quasi-experimental study
por: Nuwasiima, Afra, et al.
Publicado: (2017)

Correction to: Cost of hospital care of women with postpartum haemorrhage in India, Kenya, Nigeria and Uganda: a financial case for improved prevention
por: Theunissen, Fiona, et al.
Publicado: (2021)

A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African Nations
por: Watkins, David, et al.
Publicado: (2016)

Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)

Perceptions of HIV and Safe Male Circumcision in High HIV Prevalence Fishing Communities on Lake Victoria, Uganda
por: Nevin, Paul E., et al.
Publicado: (2015)

Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning
por: Prata, Ndola, et al.
Publicado: (2016)

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings
por: Lang, Danielle L., et al.
Publicado: (2015)

Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol
por: Ditai, James, et al.
Publicado: (2017)

Predictors and outcome of surgical repair of obstetric fistula at a regional referral hospital, Mbarara, western Uganda
por: Kayondo, Musa, et al.
Publicado: (2011)

Misoprostol for the prevention of postpartum hemorrhage during home births in rural Lao PDR: establishing a pilot program for community distribution
por: Durham, Jo, et al.
Publicado: (2018)

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012)

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date
por: Smith, Jeffrey Michael, et al.
Publicado: (2013)

Health-related quality of life and social support among women treated for abortion complications in western Uganda
por: Lubinga, Solomon J, et al.
Publicado: (2013)

Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?
por: Chatterjee, Susmita, et al.
Publicado: (2016)

Pilot evaluation of the psychometric properties of a self-medication Risk Assessment Tool among elderly patients in a community setting
por: Lubinga, Solomon J, et al.
Publicado: (2011)

Clinical guidelines—the challenges and opportunities: What we have learned from the case of misoprostol for postpartum hemorrhage
por: Morris, Jessica L., et al.
Publicado: (2018)

Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Xu, Renmei, et al.
Publicado: (2022)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
por: Cook, John R., et al.
Publicado: (2023)

Correction: Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study
por: Govorov, Igor, et al.
Publicado: (2017)

High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010)

Incidence and risk factors for postpartum hemorrhage in Uganda
por: Ononge, Sam, et al.
Publicado: (2016)

Nonproteinuric Preeclampsia among Women with Hypertensive Disorders of Pregnancy at a Referral Hospital in Southwestern Uganda
por: Owaraganise, Asiphas, et al.
Publicado: (2021)

Prevalence of postpartum depression and its association with Diabetes mellitus among mothers in Mbarara, southwestern Uganda
por: Atuhaire, Catherine, et al.
Publicado: (2023)

Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan
por: Zuberi, Nadeem F, et al.
Publicado: (2008)

The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2018)

Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
por: Sringamwong, Wirawan, et al.
Publicado: (2022)

Retracted: Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage
por: Sahhaf, Farnaz, et al.
Publicado: (2014)

Correction: Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis
por: Pichon-Riviere, Andrés, et al.
Publicado: (2015)

Factors Associated with Pregnancy Intentions Amongst Postpartum Women Living with HIV in Rural Southwestern Uganda
por: Atukunda, Esther C., et al.
Publicado: (2018)

Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage
por: Zgaya, Rym, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1gav4nq0r10l6038eccou2g8m2